Published in J Surg Oncol on November 01, 2003
Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell (2002) 5.69
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med (2012) 5.44
Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat Genet (2002) 3.06
The decision criterion of histological mixed type in "T1/T2" gastric carcinoma--comparison between TNM classification and Japanese Classification of Gastric Cancer. J Surg Oncol (2011) 1.57
Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int (2007) 1.50
Blockade of chloride ion transport enhances the cytocidal effect of hypotonic solution in gastric cancer cells. J Surg Res (2011) 1.50
Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res (2013) 1.49
Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis (2009) 1.46
Subtotal gastrectomy for cancer located in the greater curvature of the middle stomach with prevention of the left gastric artery. Am J Surg (2002) 1.46
Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET). J Surg Oncol (2003) 1.39
Secondary torsion of vermiform appendix with mucinous cystadenoma. Case Rep Gastroenterol (2007) 1.26
Comparison of effects in randomized controlled trials with observational studies in digestive surgery. Ann Surg (2006) 1.19
Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol Ther (2003) 1.18
Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin Biol Ther (2012) 1.17
Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg (2004) 1.16
The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells (2007) 1.14
Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy. World J Gastroenterol (2012) 1.12
Cisplatin incorporated in microspheres: development and fundamental studies for its clinical application. J Control Release (2003) 1.08
Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World J Surg (2004) 1.06
Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res (2013) 1.05
Tissue engineering of small intestinal tissue using collagen sponge scaffolds seeded with smooth muscle cells. Tissue Eng (2006) 1.05
Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg (2013) 1.04
Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer. Anticancer Res (2007) 1.03
Risk factors and management of postoperative bile leakage after hepatectomy without bilioenteric anastomosis. Dig Surg (2011) 1.03
Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer (2011) 1.02
XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma. Ann Surg Oncol (2012) 1.02
Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology (2003) 1.02
Chloride ions control the G1/S cell-cycle checkpoint by regulating the expression of p21 through a p53-independent pathway in human gastric cancer cells. Biochem Biophys Res Commun (2007) 1.02
Single- versus two- layer intestinal anastomosis: a meta-analysis of randomized controlled trials. BMC Surg (2006) 1.01
Clinicopathologic characteristics and prognosis of synchronous multifocal gastric carcinomas. Am J Surg (2005) 1.01
Postoperative complications following gastrectomy for gastric cancer during the last decade. Hepatogastroenterology (2004) 1.01
Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity. J Med Chem (2006) 1.01
Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer (2014) 1.01
Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol (2009) 1.01
Detection of t(11;18)(q21;q21) in marginal zone lymphoma of mucosa-associated lymphocytic tissue type on paraffin-embedded tissue sections by using fluorescence in situ hybridization. Cancer Genet Cytogenet (2003) 1.00
Furosemide, a blocker of Na+/K+/2Cl- cotransporter, diminishes proliferation of poorly differentiated human gastric cancer cells by affecting G0/G1 state. J Physiol Sci (2006) 0.99
Intra-abdominal desmoid tumor mimicking lymph node recurrence after gastrectomy for gastric cancer. J Gastroenterol Hepatol (2006) 0.99
Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer (2005) 0.98
Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers. Anticancer Res (2003) 0.98
Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol (2004) 0.98
Acute peritonitis caused by intraperitoneal rupture of an infected urachal cyst: report of a case. Surg Today (2003) 0.98
Face cooling with mist water increases cerebral blood flow during exercise: effect of changes in facial skin blood flow. Front Physiol (2012) 0.97
Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer. Anticancer Res (2007) 0.97
Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients. J Surg Oncol (2004) 0.97
Quantification of plasma cell-free DNA in patients with gastric cancer. Anticancer Res (2007) 0.96
Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer. J Surg Oncol (2011) 0.96
Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Int J Oncol (2007) 0.95
Intrathoracic esophageal replacement by in situ tissue-engineered esophagus. J Thorac Cardiovasc Surg (2008) 0.95
Initial experience with a new peroral electronic pancreatoscope with an accessory channel. Gastrointest Endosc (2004) 0.94
Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides. Jpn J Clin Oncol (2007) 0.94
Attenuated response to liver injury in moesin-deficient mice: impaired stellate cell migration and decreased fibrosis. Biochim Biophys Acta (2008) 0.94
Pleural lavage with distilled water during surgery for esophageal squamous cell carcinoma. Oncol Rep (2011) 0.93
Precise detection of lymph node metastases in mouse rectal cancer by using 5-aminolevulinic acid. Int J Cancer (2009) 0.93